French Transgene SA said it has terminated its lead programme TG4010 in combination with chemotherapy and checkpoint inhibition. 

The European biotech sector is flourishing – rising stock prices, big partnering deals, and some major M&A. Can someone please tell European fund managers that investing in biotech is simply mind over matter?!

Medical cannabis has become one of the most important economic topics in recent years! But, what makes this topic so relevant, and why is it so essential to found a European association? The legalisation of recreational and medicinal cannabis in different states has led to impressive economic progress in recent years. Through worldwide patient campaigns and global marketing strategies, the topic became a permanent information focus for social networks and politics at the end of 2018.

New research demonstrates that disruption of EGF receptor signalling allows commensal bacteria to invade hairs and cause skin lesions.

The European Circular Bio­economy Fund, which aims to provide financing for innovative circular bioeconomy companies and projects in the EU and in countries associated with the Horizon 2020 programme, will be headed by Michael Brandkamp.

Madrid-based RNA specialist Bioncotech Therapeutics has entered into a Phase II clinical trial collaboration with a MSD subsidiary.

Swiss surgeons have significantly improved mechanical removal of blood clots in stroke patients by intra-arterial administration of the thromolytic urokinase.

At the 15th Annual Scrip Awards, Mogrify Chair Jane Osbourn has been presented with the Lifetime Achievement Award. She received the award in recognition of her outstanding contribution to the biotech industry throughout her career.

Sanofi will acquire Synthorx Inc to expand its  immuno-oncology pipeline with THOR-707, an optimised IL-2 candidate.

Meatable NV, a specialist for cultivated meat, has raised an additional US$10m in seed funding, bringing the company’s total funding to US$13m.